SS Innovations Strengthens Management Team in Preparation for Global Sales Expansion
Key Highlights
- ➤SSII promotes Dr. Vishwa Srivastava to president for global operations and U.S. expansion
- ➤SSII appoints Gary Lo chief financial officer, adding more than three decades of financial leadership
- ➤SSII responds to FDA queries during review of SSi Mantra’s 510(k) notification
- ➤SSII continues pathway toward CE marking certification for SSi Mantra in Europe
- ➤SSi Mantra clinically validated in India across more than 190 surgical procedure types
Expert Statements
Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations
“At this critical juncture in SS Innovations’ growth journey, we are excited to announce the promotion of Dr. Vishwa Srivastava to President of the Company and the appointment of Gary Lo as Chief Financial Officer. Vishwa has been instrumental in the development and growth of our Asia Pacific region, and we are confident in his ability to successfully build our US business and lead our global operations during the next phase of expansion.”
Dr. Vishwa Srivastava, President of SS Innovations
“We have established a leading position in our immense home market of India, and I look forward to working closely with the team to build the required infrastructure and operations to further increase the presence of our advanced, cost-effective SSi Mantra surgical robotic system in the United States and globally in preparation for expansion. On that note, we have been responding to all queries raised by the U.S. Food and Drug Administration during its review of our 510(k) premarket notification for the SSi Mantra and we are simultaneously continuing along the pathway toward CE marking certification in the European Union. Additionally, we have been working at our R&D facility in India finalizing a pipeline of future disruptive healthcare technologies that we plan to roll out in the coming months.”
Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations
“Gary brings to SS Innovations more than three decades of financial leadership experience and a proven track record of driving profitable growth and value creation across a range of prominent technology companies, including in the medical technology sector. We expect to benefit from his capital markets expertise, multinational company experience, financial planning and analysis skills, and strategic acumen as we build a truly global organization.”
Gary Lo, Chief Financial Officer of SS Innovations
“I am thrilled to be joining the SSi team and supporting its mission to democratize access to advanced surgical robotic care. I believe that the SSi Mantra’s cutting-edge surgical robotic technology, differentiated features, user-friendliness, training capabilities, proven track record of clinical success, and cost efficiency all distinguish SS Innovations in a large and growing global market.”
Promotes Dr. Vishwa Srivastava to President and Appoints Gary Lo as Chief Financial Officer
FORT LAUDERDALE, Fla., Nov. 13, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the promotion of Dr. Vishwa Srivastava to President of the Company and the appointment of Gary Lo as Chief Financial Officer. Dr. Vishwa Srivastava previously served as the Company's Chief Executive Officer – Asia Pacific. Both executives are based in the United States.
Get started
Create a free account to read the full story.
